FR2804863A1 - Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release - Google Patents
Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release Download PDFInfo
- Publication number
- FR2804863A1 FR2804863A1 FR0001652A FR0001652A FR2804863A1 FR 2804863 A1 FR2804863 A1 FR 2804863A1 FR 0001652 A FR0001652 A FR 0001652A FR 0001652 A FR0001652 A FR 0001652A FR 2804863 A1 FR2804863 A1 FR 2804863A1
- Authority
- FR
- France
- Prior art keywords
- new compositions
- compositions according
- hydrogen peroxide
- depigmentation
- contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 230000035614 depigmentation Effects 0.000 title claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 title claims description 9
- 101710147108 Tyrosinase inhibitor Proteins 0.000 title description 5
- 238000009472 formulation Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims description 20
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 claims description 12
- 239000000499 gel Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 7
- 229960004705 kojic acid Drugs 0.000 claims description 7
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 7
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 claims description 6
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Chemical compound CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 6
- 229940043353 maltol Drugs 0.000 claims description 6
- -1 peroxide compounds Chemical class 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 5
- DGMPVYSXXIOGJY-UHFFFAOYSA-N Fusaric acid Chemical compound CCCCC1=CC=C(C(O)=O)N=C1 DGMPVYSXXIOGJY-UHFFFAOYSA-N 0.000 claims description 4
- 229940093503 ethyl maltol Drugs 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 150000002978 peroxides Chemical class 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 150000001451 organic peroxides Chemical class 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 2
- 238000000518 rheometry Methods 0.000 claims description 2
- 235000018553 tannin Nutrition 0.000 claims description 2
- 229920001864 tannin Polymers 0.000 claims description 2
- 239000001648 tannin Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- 239000007854 depigmenting agent Substances 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical class CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 5
- 229950001798 amiphenazole Drugs 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 208000000069 hyperpigmentation Diseases 0.000 description 3
- 230000003810 hyperpigmentation Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 244000101643 Aloe ferox Species 0.000 description 1
- 235000015858 Aloe ferox Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical group CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- BHXOBVQQGGHPJY-UHFFFAOYSA-N hexadecyl octadecanoate;octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC.CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC BHXOBVQQGGHPJY-UHFFFAOYSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 206010024217 lentigo Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 229940115476 ppg-1 trideceth-6 Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
<Desc/Clms Page number 1> <Desc / Clms Page number 1>
NOUVELLES COMPOSITIONS DEPIGMENTANTES
ET LEUR PROCEDE D'OBTENTION La présente invention se rapporte au domaine des nécessités de la vie et plus particulièrement au domaine de la cosméto/dermatologie et plus précisément de la cosméceutique. NEW DEPIGMENTING COMPOSITIONS
AND THEIR PROCESS FOR OBTAINING The present invention relates to the field of the necessities of life and more particularly to the field of cosmetology / dermatology and more precisely of cosmeceuticals.
L'invention concerne plus particulièrement des compositions destinées à la dépigmentation de la peau dans lesquelles le principe actif dépigmentant est renforcé d'une manière synergique par l'adjonction d'un autre principe actif, à action décolorante. The invention relates more particularly to compositions intended for depigmentation of the skin in which the depigmenting active principle is reinforced in a synergistic manner by the addition of another active principle, with bleaching action.
L'invention concerne spécifiquement des compositions cosmétologiques à action dépigmentante, dans lesquelles on inclut séparément un principe actif inhibiteur de la tyrosinase choisi dans le groupe constitué par l'acide kojique, l'acide 3-méthyl kojique, l'acide fusarique, la 5-hydroxy 2-hydroxy méthyl y-pyridone, le maltol, l'isomaltol et le 5- éthyl maltol, et un composé libérant du peroxyde d'hydrogène, dans un excipient ou un véhicule approprié pour l'application sur la peau, les muqueuses ou les téguments. The invention relates specifically to cosmetic compositions with depigmenting action, in which a tyrosinase inhibitor active ingredient is separately selected from the group consisting of kojic acid, 3-methyl kojic acid, fusaric acid, 5 -hydroxy 2-hydroxy methyl y-pyridone, maltol, isomaltol and 5-ethyl maltol, and a compound releasing hydrogen peroxide, in an excipient or a vehicle suitable for application to the skin, mucous membranes or the integuments.
La présente invention concerne aussi un produit sensiblement plus simple permettant de délivrer une préparation cosmétique à deux constituants sans que les phases fluides visqueuses ne se mélangent ou tout au moins qu'elles ne se mélangent que lors de la sortie d'un récipient tel qu'un tube ou un flacon souple, par pression. The present invention also relates to a substantially simpler product making it possible to deliver a cosmetic preparation with two constituents without the viscous fluid phases mixing or at least that they only mix when leaving a container such as a flexible tube or bottle, by pressure.
La présente invention a été réalisée en formant deux gels consistants, distincts, placés l'un au-dessus de l'autre dans le récipient et présentant des propriétés rhéologiques similaires de façon à réaliser un écoulement fluide simultané. The present invention has been achieved by forming two separate, consistent gels, placed one above the other in the container and having similar rheological properties so as to achieve a simultaneous fluid flow.
Ce dispositif s'applique tout particulièrement aux compositions dépigmentantes objet de l'invention. This device is particularly applicable to the depigmenting compositions which are the subject of the invention.
Dans les compositions dépigmentantes utilisées jusqu'ici, le problème technique à résoudre était d'obtenir une action durable et prolongée de l'inhibiteur de tyrosinase. In the depigmenting compositions used so far, the technical problem to be solved was to obtain a long-lasting and prolonged action of the tyrosinase inhibitor.
Les dérivés phénoliques et surtout polyphénoliques usuels (hydroquinone, acide cafféique, acide chlorogénique, arbutoside) sont aisément oxydables et de ce fait leur The usual phenolic and especially polyphenolic derivatives (hydroquinone, caffeic acid, chlorogenic acid, arbutoside) are easily oxidizable and therefore their
<Desc/Clms Page number 2><Desc / Clms Page number 2>
action est fugace. Une augmentation de la concentration en principe actif ne résout pas ce problème et peut entraîner des phénomènes de toxicité. action is fleeting. An increase in the concentration of active ingredient does not solve this problem and can lead to toxicity phenomena.
Il était donc important de trouver un composé qui manifeste une action dépigmentante par inhibition de la tyrosinase d'une manière prolongée, et en même temps un composé qui renforce cette action dépigmentante d'une manière synergique sans altérer les propriétés de la molécule dépigmentante. It was therefore important to find a compound which exhibits a depigmenting action by inhibiting tyrosinase in a prolonged manner, and at the same time a compound which reinforces this depigmenting action in a synergistic manner without altering the properties of the depigmenting molecule.
Ce problème a été résolu selon l'invention en additionnant dans une composition cosmétique un inhibiteur de tyrosinase du type mentionné ci-dessus, d'un dérivé libérant du peroxyde d'hydrogène, ladite composition étant présentée sous forme de deux préparations distinctes ne se mélangeant qu'au moment de l'emploi et conservant ainsi chacun des constituants dans des conditions de complète stabilité. This problem was solved according to the invention by adding to a cosmetic composition a tyrosinase inhibitor of the type mentioned above, of a derivative releasing hydrogen peroxide, said composition being presented in the form of two separate preparations which do not mix at the time of use and thus retaining each of the constituents in conditions of complete stability.
On connaît déjà un grand nombre de références de littérature qui décrivent des dispositifs de distribution d'une préparation médicinale ou cosmétique à deux composants, formés de deux conteneurs distincts et dont le contenu global vient sur l'orifice de distribution par pression ou par actionnement d'un piston ou d'une vis sans fin, pour s'y mélanger. A large number of literature references are already known which describe devices for dispensing a two-component medicinal or cosmetic preparation, formed from two separate containers and the overall content of which comes to the dispensing orifice by pressure or by actuation of the device. '' a piston or a worm, to mix.
On a décrit notamment (EP377.287) un dispositif de distribution double formé d'un sachet contenant une composition à deux composants qui sont séparés par une cloison placée dans une partie cylindrique et comprimée contre la paroi terminale comportant une sortie et une lame coupante, de telle sorte que le sachet est déchiré et que la composition est expulsée en totalité par la sortie. There has been described in particular (EP377.287) a double dispensing device formed of a sachet containing a composition with two components which are separated by a partition placed in a cylindrical part and compressed against the end wall comprising an outlet and a cutting blade, so that the bag is torn and the composition is expelled entirely through the outlet.
On a également décrit (EP331.617) la réalisation de compositions dentifrices formées d'une association de deux composants l'un étant un gel pigmenté à forte teneur en eau, et l'autre étant une pâte dentifrice blanche, dont les formulations sont différentes, dans un dispositif qui empêche la migration du gel coloré à l'interface des deux composants. We have also described (EP331.617) the production of toothpaste compositions formed from a combination of two components, one being a pigmented gel with a high water content, and the other being a white toothpaste, the formulations of which are different. , in a device which prevents the migration of the colored gel at the interface of the two components.
Cette séparation est obtenue par des consistances de gels très différentes. This separation is obtained by very different gel consistencies.
On a également décrit dans le document (EP256.012) un procédé pour mélanger intimement deux composants difficilement miscibles disposés dans deux compartiments de stockage distincts. En exerçant une pression externe sur l'emballage, les A process has also been described in document (EP256.012) for intimately mixing two hardly miscible components arranged in two separate storage compartments. By exerting external pressure on the packaging, the
<Desc/Clms Page number 3><Desc / Clms Page number 3>
composants s'écoulent dans un récipient commun tout en étant soigneusement mélangés. components flow into a common container while being thoroughly mixed.
On a décrit aussi dans le brevet français 2.705.088 un système de cartouches comprenant au moins deux chambres disposées de façon concentrique l'une par rapport à l'autre, chaque chambre comportant une douille présentant un orifice de sortie, chacun de ceux-ci étant encastré l'un dans l'autre et séparés l'un de l'autre par une paroi en forme de corde. Also described in French patent 2,705,088 is a cartridge system comprising at least two chambers arranged concentrically with respect to each other, each chamber comprising a socket having an outlet orifice, each of these being embedded one inside the other and separated from each other by a wall in the form of a rope.
On connaît encore des dispositifs de dosage et de mélange d'au moins deux composants à caractère pâteux dont les moyens de distribution sont constitués par des pompes à engrenage. There are also known metering and mixing devices for at least two pasty components, the distribution means of which are constituted by gear pumps.
Dans tous ces dispositifs on est amené à utiliser des pâtes de viscosités différentes pour éviter que les différentes couches ne se mélangent et surtout pour que l'aspect biphasique soit conservé malgré la pression exercée sur le récipient. In all these devices, it is necessary to use pastes of different viscosities to prevent the different layers from mixing and above all so that the biphasic appearance is preserved despite the pressure exerted on the container.
Le procédé utilisé pour la réalisation des compositions selon l'invention est sensiblement plus simple et plus efficace. The process used for producing the compositions according to the invention is substantially simpler and more effective.
Comme principe actif dépigmentant on accorde la préférence au Maltol, à l'isomaltol ou au 5-éthyl Maltol. As depigmenting active principle, preference is given to Maltol, isomaltol or 5-ethyl Maltol.
Comme composé peroxydé libérant du peroxyde d'hydrogène, on nommera en premier lieu l'eau oxygénée sous forme libre ou combinée à un support inerte, comme les combinaisons peroxyde d'hydrogène / acétanilide ou / urée, les peroxydes organiques comme le peroxyde de benzoyle, le peroxyde de thénoyle, le peroxyde de cumène ; les persels organiques comme, les performiates, les peracétates ou les perbenzoates, les dérivés peroxydiques minéraux comme les percarbonates, les perborates, les persilicates ou les perphosphates. On peut également utiliser des peroxydes de Noxyde d'amine tertiaire. D'une manière préférée on utilise de l'eau oxygénée et surtout de l'eau oxygénée à 20 à 100 volumes, et d'une manière particulièrement préférée de l'eau oxygénée à 30 volumes. As peroxidized compound releasing hydrogen peroxide, we will first name hydrogen peroxide in free form or combined with an inert support, like the combinations hydrogen peroxide / acetanilide or / urea, organic peroxides like benzoyl peroxide , thenoyl peroxide, cumene peroxide; organic persalts like, performiates, peracetates or perbenzoates, mineral peroxide derivatives like percarbonates, perborates, persilicates or perphosphates. Tertiary amine peroxide can also be used. Preferably, hydrogen peroxide and especially hydrogen peroxide at 20 to 100 volumes are used, and particularly preferably hydrogen peroxide at 30 volumes.
<Desc/Clms Page number 4> <Desc / Clms Page number 4>
Les compositions selon l'invention se présentent sous forme de deux préparations fluides distinctes de viscosité élevée qui ne se mélangent qu'au moment de la délivrance du produit. The compositions according to the invention are in the form of two separate fluid preparations of high viscosity which do not mix until the product is delivered.
Les compositions selon l'invention se présentent en particulier sous forme de deux gels de rhéologie équivalente, aqueux ou non aqueux, non ou peu miscibles au cours ou après leur préparation et disposés en deux couches parallèles ou concentriques dont l'une au moins présente une viscosité élevée. The compositions according to the invention are in particular in the form of two gels of equivalent rheology, aqueous or non-aqueous, not or little miscible during or after their preparation and arranged in two parallel or concentric layers, at least one of which has a high viscosity.
L'excipient visqueux sera un dérivé d'alcool cétylique ou un carbomer, de préférence une qualité pharmaceutique comme le polymer acrylique commercialisé sous la marque Carbopol 941 ou Carbopol 1322 (Goodrich). Ce peut être aussi un produit gélifiant naturel comme la gomme Xanthane, la gomme Guar, la gomme Gellan, les dérivés chimiques de gomme naturelle comme la gomme Guar cationique, ou des dérivés de la cellulose comme la méthylcellulose, l'éthylcellulose, la (p-hydroxy éthyl) cellulose, l'(hydroxy propyl) cellulose, l'hydroxypropyl méthyl cellulose et autres dérivés similaires. The viscous excipient will be a cetyl alcohol derivative or a carbomer, preferably a pharmaceutical quality such as the acrylic polymer sold under the brand Carbopol 941 or Carbopol 1322 (Goodrich). It can also be a natural gelling product such as Xanthan gum, Guar gum, Gellan gum, chemical derivatives of natural gum such as cationic Guar gum, or cellulose derivatives such as methylcellulose, ethylcellulose, (p -hydroxy ethyl) cellulose, (hydroxy propyl) cellulose, hydroxypropyl methyl cellulose and other similar derivatives.
On utilise de préférence de la cire Lanette et notamment celle commercialisée sous la dénomination Lanette C16. Le gel contient également des agents émulsionnants du type tensioactif, des agents stabilisants, des agents émolliants et des agents de régulation du pH. It is preferable to use Lanette wax and in particular that marketed under the name Lanette C16. The gel also contains emulsifying agents of the surfactant type, stabilizing agents, emollient agents and pH regulating agents.
D'une manière appropriée le gel contenant le composé inhibiteur de tyrosinase est d'une viscosité plus faible comprise entre 400 et 4. 000 m Pas. Au contraire, le gel contenant le composé libérant le peroxyde d'hydrogène sera de consistance plus élevée. Suitably the gel containing the tyrosinase inhibitor compound has a lower viscosity of between 400 and 4,000 m Pas. On the contrary, the gel containing the compound releasing the hydrogen peroxide will be of higher consistency.
La préparation peut contenir en outre des extraits de plante, notamment celles riches en phénols, en polyphénols ou en tannins, comme par exemple un extrait de racine de scutellaria ou de racine de mûrier, un extrait d'Aloè ferox ou de Reglisse (Glycirrhizha glabra) ou bien l'acide tannique lui-même. The preparation can also contain plant extracts, in particular those rich in phenols, polyphenols or tannins, such as for example an extract of scutellaria root or mulberry root, an extract of Aloe ferox or of Reglisse (Glycirrhizha glabra ) or tannic acid itself.
La préparation peut également contenir un ou plusieurs acides hydroxylés comme l'acide glycolique, l'acide glucinique, l'acide muconique, l'acide malique ou l'acide lactique. The preparation can also contain one or more hydroxyl acids such as glycolic acid, glucinic acid, muconic acid, malic acid or lactic acid.
<Desc/Clms Page number 5><Desc / Clms Page number 5>
La préparation peut également renfermer des agents photoprotecteurs notamment contre les rayons UV A et UV B. On citera à cet effet des agents organiques comme l'acide p-amino benzoïque, des caroténoïdes ou des extraits de thé, ou bien des agents minéraux comme le dioxyde de titane micronisé en suspension dans la diméthicone. The preparation can also contain photoprotective agents in particular against UV A and UV B rays. Organic agents such as p-amino benzoic acid, carotenoids or tea extracts, or mineral agents such as micronized titanium dioxide suspended in dimethicone.
Le peroxyde d'hydrogène est utilisé de préférence sous forme d'eau oxygénée de concentration allant de 10 à 100 volumes, comme par exemple l'eau oxygénée à 20 volumes ou à 30 volumes. On peut évidemment utiliser le peroxyde d'hydrogène sous une forme moins concentrée (à 5 volumes par exemple), ou sous une forme plus concentrée (à 45 volumes par exemple), à la seule condition que la préparation finale ne soit pas irritante. The hydrogen peroxide is preferably used in the form of hydrogen peroxide of concentration ranging from 10 to 100 volumes, such as for example hydrogen peroxide at 20 volumes or 30 volumes. It is obviously possible to use hydrogen peroxide in a less concentrated form (at 5 volumes for example), or in a more concentrated form (at 45 volumes for example), on the sole condition that the final preparation is not irritating.
L'agent antibactérien utilisé pour assurer la conservation et prévenir une attaque bactérienne est une paraben ou un sel d'ammonium quaternaire (sel de cetyl pyridinium ou de benzododecinium). On peut utiliser aussi avantageusement une diazolidinylurée commercialisée sous les dénominations Germaben Il ou III. The antibacterial agent used to preserve and prevent bacterial attack is a paraben or a quaternary ammonium salt (cetyl pyridinium or benzododecinium salt). A diazolidinylurea sold under the names Germaben II or III can also be advantageously used.
La préparation peut également renfermer un ou des agents régulateurs du pH comme un agent tampon pH 6 - 6,5, ou un agent neutralisant comme un carbonate de métal alcalin ou un hydroxyde de métal alcalin. De préférence le pH de la composition se situe entre 5,0 et 6,5 et de préférence entre 5,10 et 6,0. The preparation can also contain one or more pH regulating agents such as a buffer agent pH 6 - 6.5, or a neutralizing agent such as an alkali metal carbonate or an alkali metal hydroxide. Preferably the pH of the composition is between 5.0 and 6.5 and preferably between 5.10 and 6.0.
La préparation contient encore des dérivés de silicone qui améliorent la texture de la préparation, la douceur au toucher et à l'étalement, la fluidité de la préparation, comme la diméthicone, le diméthiconol, la siméthicone et des silicones similaires. The preparation also contains silicone derivatives which improve the texture of the preparation, the smoothness to the touch and spreading, the fluidity of the preparation, such as dimethicone, dimethiconol, simethicone and similar silicones.
La préparation contient encore un ou des agents émulsionnants comme le stéarate de sorbitane ou le cocoate de sucrose. Il peut encore contenir un ou des agents co- émulsionnants c'est-à-dire des composés présents à trop petites doses pour être émulsionnants mais dont l'action tensioactive faible est suffisante pour être efficace. Un exemple en est le phosphate de cétyle, sel de potassium commercialisé sous la dénomination Amphisol K. The preparation also contains one or more emulsifying agents such as sorbitan stearate or sucrose cocoate. It may also contain one or more co-emulsifying agents, that is to say compounds present in too small doses to be emulsifying but whose weak surfactant action is sufficient to be effective. An example is cetyl phosphate, potassium salt marketed under the name Amphisol K.
Les compositions selon l'invention peuvent en outre être additionnées d'un colorant, d'un pigment, d'un parfum ou d'un produit donnant un aspect nacré. The compositions according to the invention can also be added with a dye, a pigment, a perfume or a product giving a pearly appearance.
<Desc/Clms Page number 6><Desc / Clms Page number 6>
Les compositions selon l'invention trouvent un emploi en cosmétique pour assurer une dépigmentation de la peau et des teguments ainsi que dans les cas d'hyperpigmentation ou de pigmentation irrégulière. The compositions according to the invention find use in cosmetics to ensure depigmentation of the skin and the integuments as well as in the case of hyperpigmentation or irregular pigmentation.
Les compositions selon l'invention trouvent également un emploi en dermatologie pour le traitement de l'hyperactivité melanocytaire et d'hyperpigmentation liée à la prolifération des mélanocytes. On citera à cet égard le traitement des éphélides ou taches de son, du lentigo solaire et du lentigo de la vieillesse. On citera tout particulièrement le traitement des taches pigmentaires qui apparaissent sur la face supérieure des mains, notamment chez les personnes âgées, sur les avant-bras, et sur le visage. Cette manifestation se traduit par une hyperpigmentation de la couche basse de l'épiderme et par une augmentation du nombre de melanocytes. The compositions according to the invention also find use in dermatology for the treatment of melanocytic hyperactivity and of hyperpigmentation linked to the proliferation of melanocytes. In this regard, mention may be made of the treatment of ephelids or sound spots, solar lentigo and lentigo of old age. Mention will be made in particular of the treatment of pigment spots which appear on the upper face of the hands, in particular in the elderly, on the forearms, and on the face. This manifestation results in hyperpigmentation of the lower layer of the epidermis and in an increase in the number of melanocytes.
La composition selon l'invention sera à cette fin appliquée de 1 à 4 fois par jour sur la partie concernée pendant 30 jours à 90 jours consécutivement. To this end, the composition according to the invention will be applied from 1 to 4 times a day on the part concerned for 30 days to 90 days consecutively.
Les compositions selon l'invention ne manifestent aucune toxicité ni aucune intolérance locale. Elles ne sont pas allergisantes. The compositions according to the invention do not show any local toxicity or intolerance. They are not allergenic.
EXEMPLE1 Préparation d'une crème bicouche à base de Maltol. EXAMPLE 1 Preparation of a bilayer cream based on Maltol.
Crème n 1 Lanette 16 (alcool cetylique) 2 Incroquat Behenyl TMC (mélange de chlorure de béhényltrimonium et d'alcool cétearylique) 2 Lecinol S-10 (lecithine hydrogénée) 0,30 Amphisol K (Cetyl phosphate de potassium) 1 Transcutol (ethoxydiglycol) 2,50 Glycyrrhetinate de stéaryle 0,15 Cetiol OE (éther dicaprylique) 2 Cosmacol ELI (lactate d'alkyle en C12 - C13) 2,50 Cream No. 1 Lanette 16 (cetyl alcohol) 2 Incroquat Behenyl TMC (mixture of behenyltrimonium chloride and cetearyl alcohol) 2 Lecinol S-10 (hydrogenated lecithin) 0.30 Amphisol K (potassium cetyl phosphate) 1 Transcutol (ethoxydiglycol) 2.50 Stearyl glycyrrhetinate 0.15 Cetiol OE (dicaprylic ether) 2 Cosmacol ELI (C12-C13 alkyl lactate) 2.50
<Desc/Clms Page number 7> <Desc / Clms Page number 7>
DC - 1403 fluide (mélange de diméthiconol et de diméthicone ) 0,75
Salcare SC96 (mélange de dicaprate de propylène
Glycol, de polyquaternium-37 et PPG-1 Trideceth-6) 2
Complexe Photoprotecteur 5
Propylène Glycol 2 Arlatone 2121 (mélange de stéarate de sorbitane et de Cocoate de sucrose) 4 Germaben ## 0,70
Eau qs Acide Gluconique 3 Acide Glycolique ou Acide lactique 5 Acide Tannique (Tanlex VB) 2,5 Maltol 2,20 Arbutoside 2 Parfum fleurs 0,30 (parfum Lotus AF3817) Hydroxyde de sodium qsp pH 5,20 Skinone = agent dépigmentant à base d'acide Kojique 10 Crème n 2 Eau oxygénée à 30 volumes 4 g Eau qsp 79,38 g EDTA 0,20 g Germaben ## 0,70 g Acide phosphorique 0,015 g Emulsium A (agent tensioactif formé d'alcool cétylique, de stéarate de glyceryle PEG 75 et de stéarate de cetéaryl 20 OE) Amphisol K (potassium cétyl phosphate) 0,70 Isononanoate d'isononanoyle 5 Cire Lanette C16 2 Hydroxyde de sodium à 32 % qsp pH voisin 5,0 DC - 1403 fluid (mixture of dimethiconol and dimethicone) 0.75
Salcare SC96 (mixture of propylene dicaprate
Glycol, polyquaternium-37 and PPG-1 Trideceth-6) 2
Photoprotective complex 5
Propylene Glycol 2 Arlatone 2121 (mixture of sorbitan stearate and Sucrose cocoate) 4 Germaben ## 0.70
Water qs Gluconic Acid 3 Glycolic Acid or Lactic Acid 5 Tannic Acid (Tanlex VB) 2.5 Maltol 2.20 Arbutoside 2 Flower scent 0.30 (Lotus AF3817 scent) Sodium hydroxide qs pH 5.20 Skinone = base depigmenting agent Kojic acid 10 Cream n 2 Hydrogen peroxide at 30 volumes 4 g Water qs 79.38 g EDTA 0.20 g Germaben ## 0.70 g Phosphoric acid 0.015 g Emulsium A (surfactant formed from cetyl alcohol, stearate PEG 75 glyceryl and cetearyl stearate 20 EO) Amphisol K (potassium cetyl phosphate) 0.70 Isononanoyl isononanoate 5 Lanette wax C16 2 Sodium hydroxide at 32% qs pH 5.0
<Desc/Clms Page number 8><Desc / Clms Page number 8>
EXEMPLE 2 Crème bicouche à base d'acide Kojique Crème n 1 1 Eau oxygénée à 30 volumes 8 Eau qsp 158,77 g EDTA 0,42 Germaben Il 1,4 Acide othophosphorique 0,03 Emulsium 16 Amphisol K 1,4 Isononanoate d'isononanoyle 10 Cire Lanette C16 4 NaOH à 33 % 0,147 g La préparation est ajustée à un pH de 5,13 Crème n 2 Alcool cetylique 4 Lécithine hydrogénée 0,30 Amphisol K 1 Ether dicaprylique 1 DC - 1401 2 Propylène glycol 2 Acide Kojique 10 g EDTA 0,5 g Sulfite de sodium 0,3 g Metabisulfite de potassium 0,3 g Acide Glycolique 8,5 g Tanlex VB 2 g Extrait de pamplemousse 0,75 g Extrait de mûre blanche 3 g Extrait de citron dans le butylène glycol 2,5 g H20 80,5 g EXAMPLE 2 Double-layer cream based on Kojic acid Cream n 1 1 Hydrogen peroxide at 30 volumes 8 Water qs 158.77 g EDTA 0.42 Germaben Il 1.4 Otophosphoric acid 0.03 Emulsium 16 Amphisol K 1.4 Isononanoate isononanoyl 10 Lanette C16 wax 4 33% NaOH 0.147 g The preparation is adjusted to a pH of 5.13 Cream No. 2 Cetyl alcohol 4 Hydrogenated lecithin 0.30 Amphisol K 1 Dicaprylic ether 1 DC - 1401 2 Propylene glycol 2 Kojic acid 10 g EDTA 0.5 g Sodium sulfite 0.3 g Potassium metabisulfite 0.3 g Glycolic Acid 8.5 g Tanlex VB 2 g Grapefruit extract 0.75 g White blackberry extract 3 g Lemon extract in butylene glycol 2.5 g H2O 80.5 g
Claims (16)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001652A FR2804863A1 (en) | 2000-02-10 | 2000-02-10 | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001652A FR2804863A1 (en) | 2000-02-10 | 2000-02-10 | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2804863A1 true FR2804863A1 (en) | 2001-08-17 |
Family
ID=8846849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR0001652A Pending FR2804863A1 (en) | 2000-02-10 | 2000-02-10 | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2804863A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932511A3 (en) * | 2006-11-30 | 2009-01-21 | Oreal | Peeling process based on a cationic microgel |
| CN102458345A (en) * | 2009-06-19 | 2012-05-16 | 花王株式会社 | Double layer separation type hair cosmetics |
| WO2012019688A3 (en) * | 2010-07-27 | 2012-05-24 | Clariant International Ltd | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances |
| WO2012019689A3 (en) * | 2010-07-27 | 2012-05-24 | Clariant International Ltd | Use of hydroxypyridones or salts thereof for stabilizing hydrogen peroxide or hydrogen peroxide donor substances |
| WO2012079739A1 (en) * | 2010-12-17 | 2012-06-21 | Clariant International Ltd | Compositions containing hydrogen peroxide or substances releasing hydrogen peroxide |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0419901A1 (en) * | 1989-09-14 | 1991-04-03 | Sansho Seiyaku Co., Ltd. | Endermic preparation for external application |
| EP0422466A1 (en) * | 1989-10-09 | 1991-04-17 | Sansho Seiyaku Co., Ltd. | Endermic preparation of external application |
| FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
| US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
| WO1998058628A1 (en) * | 1997-06-20 | 1998-12-30 | Mary Kay Inc. | Cosmetic composition containing a whitening agent and an exfoliant |
-
2000
- 2000-02-10 FR FR0001652A patent/FR2804863A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0419901A1 (en) * | 1989-09-14 | 1991-04-03 | Sansho Seiyaku Co., Ltd. | Endermic preparation for external application |
| EP0422466A1 (en) * | 1989-10-09 | 1991-04-17 | Sansho Seiyaku Co., Ltd. | Endermic preparation of external application |
| US5609875A (en) * | 1994-03-17 | 1997-03-11 | Fischer Pharmaceuticals Ltd. | Skin whitening composition |
| FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
| WO1998058628A1 (en) * | 1997-06-20 | 1998-12-30 | Mary Kay Inc. | Cosmetic composition containing a whitening agent and an exfoliant |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1932511A3 (en) * | 2006-11-30 | 2009-01-21 | Oreal | Peeling process based on a cationic microgel |
| CN102458345A (en) * | 2009-06-19 | 2012-05-16 | 花王株式会社 | Double layer separation type hair cosmetics |
| CN102458345B (en) * | 2009-06-19 | 2014-07-16 | 花王株式会社 | Separated two-layer hair cosmetic |
| CN103124690A (en) * | 2010-07-27 | 2013-05-29 | 科莱恩金融(Bvi)有限公司 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances |
| CN103118973A (en) * | 2010-07-27 | 2013-05-22 | 科莱恩金融(Bvi)有限公司 | Use of hydroxypyridones or salts thereof for stabilizing hydrogen peroxide or hydrogen peroxide donor substances |
| WO2012019689A3 (en) * | 2010-07-27 | 2012-05-24 | Clariant International Ltd | Use of hydroxypyridones or salts thereof for stabilizing hydrogen peroxide or hydrogen peroxide donor substances |
| WO2012019688A3 (en) * | 2010-07-27 | 2012-05-24 | Clariant International Ltd | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances |
| US9090467B2 (en) | 2010-07-27 | 2015-07-28 | Clariant Finance (Bvi) Limited | Method of stabilizing hydrogen peroxide or hydrogen peroxide donor substances with hydroxypyridones or salts therof |
| CN103118973B (en) * | 2010-07-27 | 2016-03-23 | 科莱恩金融(Bvi)有限公司 | Pyridone ketone or its salt are used for the purposes of the material of stabilization hydrogen peroxide or release hydrogen peroxide |
| US11110121B2 (en) | 2010-07-27 | 2021-09-07 | Clariant International Ltd. | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances |
| WO2012079739A1 (en) * | 2010-12-17 | 2012-06-21 | Clariant International Ltd | Compositions containing hydrogen peroxide or substances releasing hydrogen peroxide |
| CN103313932A (en) * | 2010-12-17 | 2013-09-18 | 科莱恩金融(Bvi)有限公司 | Compositions containing hydrogen peroxide or hydrogen peroxide-releasing substances |
| CN103313932B (en) * | 2010-12-17 | 2016-11-23 | 科莱恩金融(Bvi)有限公司 | Compositions containing hydrogen peroxide or hydrogen peroxide-releasing substances |
| US9592185B2 (en) | 2010-12-17 | 2017-03-14 | Clariant International Ltd. | Compositions containing hydrogen peroxide or substances releasing hydrogen peroxide |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2787960B1 (en) | Novel oil-in-water emulsions enriched with salt which are highly viscous and stable over time | |
| US9499419B2 (en) | Methods and compositions for treatment of skin | |
| CA1274178A (en) | Use of 2,3-indolinedione to dye keratinic fibers | |
| EP2459155B1 (en) | Oil-in-water emulsion having improved sensory properties | |
| CA1177606A (en) | Benzaldehyde hydroxylated derivatives useful for dyeing keratinic fibres, process and composition used | |
| EP2941303B1 (en) | Novel oil-in-water emulsions rich in salts, having high viscosity and stable over time | |
| CN103025311A (en) | Menthyl carbamate compounds as skin and/or hair lightening actives | |
| FR2789329A1 (en) | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONSISTING OF AN OIL-IN-WATER-TYPE EMULSION FORMED BY LIPID VESICLES DISPERSE IN AN AQUEOUS PHASE CONTAINING AT LEAST ONE HYDROPHILIC ACID ACTIVE | |
| EP2196181A2 (en) | Cosmetic composition comprising at least one ortho-diphenol, one metal salt, hydrogen peroxide, (bi)carbonate and a surface-active agent, and dyeing method based on the composition | |
| JP2009517429A (en) | Glucan composition | |
| CH651842A5 (en) | POLYETHYLENE GLYCOLS DERIVATIVES, THEIR USE AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| WO2007099398A2 (en) | Methods and compositions for treatment of skin | |
| EP2196183B1 (en) | Dyeing method based on ortho-diphenol and comprising a wiping, drying or non rinsing stage | |
| FR2820975A1 (en) | COMPOSITION FOR TOPICAL APPLICATION COMPRISING AT LEAST ONE HYDROXYSTILBENE AND AT LEAST ONE POLYOL FOR SOLUBILIZING THE HYDROXYSTILBENE | |
| FR2844715A1 (en) | Cosmetic, pharmaceutical or food supplement compositions, comprising resveratrol oligomer or derivative, optionally as plant extract, useful for combating disorders of skin or exoskeleton, e.g. acne or dry skin | |
| CN1235560C (en) | Use of ascorbic-acid dervative as bleaching agent for beauty | |
| FR3004944A1 (en) | COMPOSITION COMPRISING HENNE AND / OR INDIGO, A FATTY BODY, A (BI) CARBONATE, AND AN ACID, AND A CAPILLARY COLORING METHOD IMPLEMENTING THE SAME | |
| FR2969924A1 (en) | COMPOSITION COMPRISING A TOCOPHEROL PHOSPHATE | |
| FR2742674A1 (en) | STABLE DISPERSION OF A PHASE NOT MISCIBLE TO WATER, IN AN AQUEOUS PHASE BY MEANS OF VESICLES BASED ON SILICONE SURFACTANT | |
| FR2844714A1 (en) | Cosmetic, pharmaceutical or food supplement compositions, comprising resveratrol oligomer or derivative, optionally as plant extract, useful for combating hormonal disorders of skin or exoskeleton and effects of age, e.g. wrinkles | |
| EP1486193A1 (en) | Method of stabilizing silicone oil-containing cosmetic composition | |
| FR2804863A1 (en) | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release | |
| JP2003176221A (en) | Skin care preparation | |
| LU83807A1 (en) | USE OF BENZOQUINONES FOR THE DIRECT COLORING OF KERATINIC FIBERS | |
| ES2651006T3 (en) | Use of orange essential oil to treat skin pigmentation disorders |